Pathogenesis and treatments of TGFBI corneal dystrophies

Progress in Retinal and Eye Research

Volumn 50, Issue , 2016, Pages 67-88

  Han, Kyung Eun ^a   Choi, Seung Il ^b   Kim, Tae Im ^b   Maeng, Yong Sun ^b   Stulting, R Doyle ^c   Ji, Yong Woo ^b   Kim, Eung Kweon ^b  

^a Ewha Womans University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Woolfson Eye Institute   (United States)

Author keywords

Genetics; Granular corneal dystrophy type 2; Molecular mechanism; Transforming growth factor beta induced corneal dystrophies; Transforming growth factor beta induced protein

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

AUTOPHAGY; CORNEA; CORNEAL DYSTROPHIES, HEREDITARY; FIBROBLAST; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; MUTATION; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY;

AUTOPHAGY; CORNEA; CORNEAL DYSTROPHIES, HEREDITARY; FIBROBLASTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; OXIDATIVE STRESS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84955421424     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2015.11.002     Document Type: Review

References (252)

1. Afshari N.A., Mullally J.E., Afshari M.A., Steinert R.F., Adamis A.P., Azar D.T., Talamo J.H., Dohlman C.H., Dryja T.P. Survey of patients with granular, lattice, avellino, and Reis-Bucklers corneal dystrophies for mutations in the BIGH3 and gelsolin genes. Arch. Ophthalmol. 2001, 119:16-22.
2. Akhtar S., Meek K.M., Ridgway A.E., Bonshek R.E., Bron A.J. Deposits and proteoglycan changes in primary and recurrent granular dystrophy of the cornea. Arch. Ophthalmol. 1999, 117:310-321.
3. Akiya S., Brown S.I. Granular dystrophy of the cornea. Characteristic electron microscopic lesion. Arch. Ophthalmol. 1970, 84:179-192.
4. Akiya S., Takahashi H., Nakano N., Hirose N., Tokuda Y. Granular-lattice (Avellino) corneal dystrophy. Ophthalmol. J. Int. d'ophtalmol. Int. J. Ophthalmol. Z. fur Augenheilkd. 1999, 213:58-62.
5. Aldave A.J., Gutmark J.G., Yellore V.S., Affeldt J.A., Meallet M.A., Udar N., Rao N.A., Small K.W., Klintworth G.K. Lattice corneal dystrophy associated with the Ala546Asp and Pro551Gln missense changes in the TGFBI gene. Am. J. Ophthalmol. 2004, 138:772-781.
6. Aldave A.J., Rayner S.A., Kim B.T., Prechanond A., Yellore V.S. Unilateral lattice corneal dystrophy associated with the novel His572del mutation in the TGFBI gene. Mol. Vis. 2006, 12:142-146.
7. Aldave A.J., Sonmez B., Forstot S.L., Rayner S.A., Yellore V.S., Glasgow B.J. A clinical and histopathologic examination of accelerated TGFBIp deposition after LASIK in combined granular-lattice corneal dystrophy. Am. J. Ophthalmol. 2007, 143:416-419.
8. Aldave A.J., Yellore V.S., Sonmez B., Bourla N., Salem A.K., Khan M.A., Rayner S.A., Glasgow B.J. A novel variant of combined granular-lattice corneal dystrophy associated with the Met619Lys mutation in the TGFBI gene. Arch. Ophthalmol. 2008, 126:371-377.
9. American Academy of Ophthalmology External diseases and cornea. Basic and Clinical Sciences Course 2007-2008 2007, 305-329. American Academy of Ophthalmology, San Francisco, CA. J.E. Sutphin (Ed.).
10. Andreasen M., Nielsen S.B., Runager K., Christiansen G., Nielsen N.C., Enghild J.J., Otzen D.E. Polymorphic fibrillation of the destabilized fourth fasciclin-1 domain mutant A546T of the transforming growth factor-beta-induced protein (TGFBIp) occurs through multiple pathways with different oligomeric intermediates. J. Biol. Chem. 2012, 287:34730-34742.
11. Andreasen M., Lorenzen N., Otzen D. Interactions between misfolded protein oligomers and membranes: a central topic in neurodegenerative diseases?. Biochim. Biophys. Acta 2015, 1848:1897-1907.
12. Atchaneeyasakul L.O., Appukuttan B., Pingsuthiwong S., Yenchitsomanus P.T., Trinavarat A., Srisawat C. A novel H572R mutation in the transforming growth factor-beta-induced gene in a Thai family with lattice corneal dystrophy type I. Jpn. J. Ophthalmol. 2006, 50:403-408.
13. Awwad S.T., Di Pascuale M.A., Hogan R.N., Forstot S.L., McCulley J.P., Cavanagh H.D. Avellino corneal dystrophy worsening after laser in situ keratomileusis: further clinicopathologic observations and proposed pathogenesis. Am. J. Ophthalmol. 2008, 145:656-661.
14. Azar D.T., Jain S. Topical MMC for subepithelial fibrosis after refractive corneal surgery. Ophthalmology 2001, 108:239-240.
15. Banning C.S., Kim W.C., Randleman J.B., Kim E.K., Stulting R.D. Exacerbation of avellino corneal dystrophy after LASIK in North America. Cornea 2006, 25:482-484.
16. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 1997, 272:20313-20316.
17. Bücklers M. Die erblichen Hornhaut-dystrophie. Klin. Monatsbl. Augenheilkd. 1938, 3:1-135.
18. Bücklers M. Uber eine weitere familiare Hornhautdystrophie (Reis). Klin. Monatsbl. Augenheilkd. 1949, 114:386-397.
19. Bustamante M., Tasinato A., Maurer F., Elkochairi I., Lepore M.G., Arsenijevic Y., Pedrazzini T., Munier F.L., Schorderet D.F. Overexpression of a mutant form of TGFBI/BIGH3 induces retinal degeneration in transgenic mice. Mol. Vis. 2008, 14:1129-1137.
20. Cao W., Ge H., Cui X., Zhang L., Bai J., Fu S., Liu P. Reduced penetrance in familial Avellino corneal dystrophy associated with TGFBI mutations. Mol. Vis. 2009, 15:70-75.
21. Carson D.D., Lagow E., Thathiah A., Al-Shami R., Farach-Carson M.C., Vernon M., Yuan L., Fritz M.A., Lessey B. Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol. Hum. Reprod. 2002, 8:871-879.
22. Chakravarthi S.V., Kannabiran C., Sridhar M.S., Vemuganti G.K. TGFBI gene mutations causing lattice and granular corneal dystrophies in Indian patients. Invest. Ophthalmol. Vis. Sci. 2005, 46:121-125.
23. Chang L., Zhiqun W., Shijing D., Chen Z., Qingfeng L., Li L., Xuguang S. Arg124Cys mutation of the TGFBI gene in 2 Chinese families with Thiel-Behnke corneal dystrophy. Arch. Ophthalmol. 2009, 127:641-644.
24. Cheng Z. Protein translocation through the Sec61/SecY channel. Biosci. Rep. 2010, 30:201-207.
25. Chiu E.K., Lin A.Y., Folberg R., Saidel M. Avellino dystrophy in a patient after laser-assisted in situ keratomileusis surgery manifesting as granular dystrophy. Arch. Ophthalmol. 2007, 125:703-705.
26. Cho K.J., Mok J.W., Na K.S., Rho C.R., Byun Y.S., Hwang H.S., Hwang K.Y., Joo C.K. TGFBI gene mutations in a Korean population with corneal dystrophy. Mol. Vis. 2012, 18:2012-2021.
27. Choi S.I., Dadakhujaev S., Maeng Y.S., Ahn S.Y., Kim T.I., Kim E.K. Disrupted cell cycle arrest and reduced proliferation in corneal fibroblasts from GCD2 patients: a potential role for altered autophagy flux. Biochem. Biophys. Res. Commun. 2015, 456:288-293.
28. Choi S.I., Dadakhujaev S., Ryu H., Im Kim T., Kim E.K. Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors. J. Pineal Res. 2011, 51:94-103.
29. Choi S.I., Kim B.Y., Dadakhujaev S., Jester J.V., Ryu H., Kim T.I., Kim E.K. Inhibition of TGFBIp expression by lithium: implications for TGFBI-linked corneal dystrophy therapy. Invest. Ophthalmol. Vis. Sci. 2011, 52:3293-3300.
30. Choi S.I., Kim B.Y., Dadakhujaev S., Oh J.Y., Kim T.I., Kim J.Y., Kim E.K. Impaired autophagy and delayed autophagic clearance of transforming growth factor beta-induced protein (TGFBI) in granular corneal dystrophy type 2. Autophagy 2012, 8:1782-1797.
31. Choi S.I., Kim K.S., Oh J.Y., Jin J.Y., Lee G.H., Kim E.K. Melatonin induces autophagy via an mTOR-dependent pathway and enhances clearance of mutant-TGFBIp. J. Pineal Res. 2013, 54:361-372.
32. Choi S.I., Kim T.I., Kim K.S., Kim B.Y., Ahn S.Y., Cho H.J., Lee H.K., Cho H.S., Kim E.K. Decreased catalase expression and increased susceptibility to oxidative stress in primary cultured corneal fibroblasts from patients with granular corneal dystrophy type II. Am. J. Pathol. 2009, 175:248-261.
33. Choi S.I., Maeng Y.S., Kim K.S., Kim T.I., Kim E.K. Autophagy is induced by raptor degradation via the ubiquitin/proteasome system in granular corneal dystrophy type 2. Biochem. Biophys. Res. Commun. 2014, 450:1505-1511.
34. Choi S.I., Maeng Y.S., Kim T.I., Lee Y., Kim Y.S., Kim E.K. Lysosomal trafficking of TGFBIp via caveolae-mediated endocytosis. PloS One 2015, 10:e0119561.
35. Choi S.I., Yoo Y.M., Kim B.Y., Kim T.I., Cho H.J., Ahn S.Y., Lee H.K., Cho H.S., Kim E.K. Involvement of TGF-receptor- and integrin-mediated signaling pathways in the pathogenesis of granular corneal dystrophy II. Invest. Ophthalmol. Vis. Sci. 2010, 51:1832-1847.
36. Ciechanover A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nature reviews. Mol. Cell Biol. 2005, 6:79-87.
37. Clout N.J., Hohenester E. A model of FAS1 domain 4 of the corneal protein beta(ig)-h3 gives a clearer view on corneal dystrophies. Mol. Vis. 2003, 9:440-448.
38. Correa-Gomez V., Villalvazo-Cordero L., Zenteno J.C. The TGFBI A546D mutation causes an atypical type of lattice corneal dystrophy. Mol. Vis. 2007, 13:1695-1700.
39. Courtney D.G., Atkinson S.D., Moore J.E., Maurizi E., Serafini C., Pellegrini G., Black G.C., Manson F.D., Yam G.H., Macewen C.J., Allen E.H., McLean W.H., Moore C.B. Development of allele-specific gene-silencing siRNAs for TGFBI Arg124Cys in lattice corneal dystrophy type I. Invest. Ophthalmol. Vis. Sci. 2014, 55:977-985.
40. Cuervo A.M. Autophagy: in sickness and in health. Trends Cell Biol. 2004, 14:70-77.
41. Dalle-Donne I., Giustarini D., Colombo R., Rossi R., Milzani A. Protein carbonylation in human diseases. Trends Mol. Med. 2003, 9:169-176.
42. Das S., Langenbucher A., Seitz B. Excimer laser phototherapeutic keratectomy for granular and lattice corneal dystrophy: a comparative study. J. Refract Surg. 2005, 21:727-731.
43. Dighiero P., Drunat S., D'Hermies F., Renard G., Delpech M., Valleix S. A novel variant of granular corneal dystrophy caused by association of 2 mutations in the TGFBI gene-R124L and DeltaT125-DeltaE126. Arch. Ophthalmol. 2000, 118:814-818.
44. Dighiero P., Drunat S., Ellies P., D'Hermies F., Savoldelli M., Legeais J.M., Renard G., Delpech M., Grateau G., Valleix S. A new mutation (A546T) of the betaig-h3 gene responsible for a French lattice corneal dystrophy type IIIA. Am. J. Ophthalmol. 2000, 129:248-251.
45. Dighiero P., Niel F., Ellies P., D'Hermies F., Savoldelli M., Renard G., Delpech M., Valleix S. Histologic phenotype-genotype correlation of corneal dystrophies associated with eight distinct mutations in the TGFBI gene. Ophthalmology 2001, 108:818-823.
46. Dinh R., Rapuano C.J., Cohen E.J., Laibson P.R. Recurrence of corneal dystrophy after excimer laser phototherapeutic keratectomy. Ophthalmology 1999, 106:1490-1497.
47. Dogru M., Katakami C., Nishida T., Yamanaka A. Alteration of the ocular surface with recurrence of granular/avellino corneal dystrophy after phototherapeutic keratectomy: report of five cases and literature review. Ophthalmology 2001, 108:810-817.
48. Dunaief J.L., Ng E.W., Goldberg M.F. Corneal dystrophies of epithelial genesis: the possible therapeutic use of limbal stem cell transplantation. Arch. Ophthalmol. 2001, 119:120-122.
49. Dyrlund T.F., Poulsen E.T., Scavenius C., Nikolajsen C.L., Thogersen I.B., Vorum H., Enghild J.J. Human cornea proteome: identification and quantitation of the proteins of the three main layers including epithelium, stroma, and endothelium. J. Proteome Res. 2012, 11:4231-4239.
50. Eggink F.A., Geerards A.J., Beekhuis W.H. Recovery of the visual acuity in a family with Reis-Buckler dystrophy. Cont. Lens Anterior Eye 2002, 25:67-72.
51. Eifrig D.E., Afshari N.A., Buchanan H.W.t., Bowling B.L., Klintworth G.K. Polymorphic corneal amyloidosis: a disorder due to a novel mutation in the transforming growth factor beta-induced (BIGH3) gene. Ophthalmology 2004, 111:1108-1114.
52. El-Shabrawi Y., Kublin C.L., Cintron C. mRNA levels of alpha1(VI) collagen, alpha1(XII) collagen, and beta ig in rabbit cornea during normal development and healing. Invest. Ophthalmol. Vis. Sci. 1998, 39:36-44.
53. El Kochairi I., Letovanec I., Uffer S., Munier F.L., Chaubert P., Schorderet D.F. Systemic investigation of keratoepithelin deposits in TGFBI/BIGH3-related corneal dystrophy. Mol. Vis. 2006, 12:461-466.
54. Ellies P., Renard G., Valleix S., Boelle P.Y., Dighiero P. Clinical outcome of eight BIGH3-linked corneal dystrophies. Ophthalmology 2002, 109:793-797.
55. Endo S., Nguyen T.H., Fujiki K., Hotta Y., Nakayasu K., Yamaguchi T., Ishida N., Kanai A. Leu518Pro mutation of the beta ig-h3 gene causes lattice corneal dystrophy type I. Am. J. Ophthalmol. 1999, 128:104-106.
56. Escribano J., Hernando N., Ghosh S., Crabb J., Coca-Prados M. cDNA from human ocular ciliary epithelium homologous to beta ig-h3 is preferentially expressed as an extracellular protein in the corneal epithelium. J. Cell. Physiol. 1994, 160:511-521.
57. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11:81-128.
58. Fan Y., Shen B., Tan M., Mu X., Qin Y., Zhang F., Liu Y. TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin. cancer Res. Off. J. Am. Assoc. Cancer Res. 2014, 20:1531-1541.
59. Fandrich M., Fletcher M.A., Dobson C.M. Amyloid fibrils from muscle myoglobin. Nature 2001, 410:165-166.
60. Feizi S., Pakravan M., Baradaran-Rafiee A.R., Yazdani S. Granular corneal dystrophy manifesting after radial keratotomy. Cornea 2007, 26:1267-1269.
61. Ferguson J.W., Thoma B.S., Mikesh M.F., Kramer R.H., Bennett K.L., Purchio A., Bellard B.J., LeBaron R.G. The extracellular matrix protein betaIG-H3 is expressed at myotendinous junctions and supports muscle cell adhesion. Cell Tissue Res. 2003, 313:93-105.
62. Ferguson J.W., Mikesh M.F., Wheeler E.F., LeBaron R.G. Developmental expression patterns of Beta-ig (betaIG-H3) and its function as a cell adhesion protein. Mech. Dev. 2003, 120:851-864.
63. Folberg R., Alfonso E., Croxatto J.O., Driezen N.G., Panjwani N., Laibson P.R., Boruchoff S.A., Baum J., Malbran E.S., Fernandez-Meijide R., et al. Clinically atypical granular corneal dystrophy with pathologic features of lattice-like amyloid deposits. A study of these families. Ophthalmology 1988, 95:46-51.
64. Francois J., Feher J. Light microscopical and polarisation optical study of the lattice dystrophy of the cornea. Ophthalmol. J. Int. d'ophtalmol. Int. J. Ophthalmol. Z. fur Augenheilkd. 1972, 164:1-18.
65. Frising M., Wildhardt G., Frisch L., Pitz S. Recurrent granular dystrophy of the cornea: an unusual case. Cornea 2006, 25:614-617.
66. Fu L., Kim Y.A., Wang X., Wu X., Yue P., Lonial S., Khuri F.R., Sun S.Y. Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy. Cancer Res. 2009, 69:8967-8976.
67. Fujiki K., Hotta Y., Nakayasu K., Yokoyama T., Takano T., Yamaguchi T., Kanai A. A new L527R mutation of the betaIGH3 gene in patients with lattice corneal dystrophy with deep stromal opacities. Hum. Genet. 1998, 103:286-289.
68. Fujiki K., Nakayasu K., Kanai A. Corneal dystrophies in Japan. J. Hum. Genet. 2001, 46:431-435.
69. Groenouw A. Knötchenförmige Hornhauttrübungen 'Noduli Corneae.'. Arch. Augenheilkd. 1890, 21:281-289.
70. Gruenauer-Kloevekorn C., Clausen I., Weidle E., Wolter-Roessler M., Tost F., Volcker H.E., Schulze D.P., Heinritz W., Reinhard T., Froster U., Duncker G., Schorderet D., Auw-Haedrich C. TGFBI (BIGH3) gene mutations in German families: two novel mutations associated with unique clinical and histopathological findings. Br. J. Ophthalmol. 2009, 93:932-937.
71. Gutteridge J.M., Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem. Sci. 1990, 15:129-135.
72. Ha B.J., Kim T.I., Choi S.I., Stulting R.D., Lee D.H., Cho H.S., Kim E.K. Mitomycin C does not inhibit exacerbation of granular corneal dystrophy type II induced by refractive surface ablation. Cornea 2010, 29:490-496.
73. Ha N.T., Cung le X., Chau H.M., Thanh T.K., Fujiki K., Murakami A., Kanai A. A novel mutation of the TGFBI gene found in a Vietnamese family with atypical granular corneal dystrophy. Jpn. J. Ophthalmol. 2003, 47:246-248.
74. Halliwell B., Gutteridge J. Free Radicals in Biology and Medicine 1989, Clarendon, Oxford. second ed.
75. Han K.E., Choi S.I., Chung W.S., Jung S.H., Katsanis N., Kim T.I., Kim E.K. Extremely varied phenotypes in granular corneal dystrophy type 2 heterozygotes. Mol. Vis. 2012, 18:1755-1762.
76. Han K.E., Chung W.S., Kim T., Kim K.S., Kim T.I., Kim E.K. Changes of clinical manifestation of granular corneal deposits because of recurrent corneal erosion in granular corneal dystrophy types 1 and 2. Cornea 2013, 32:e113-120.
77. Han K.E., Kim T.I., Chung W.S., Choi S.I., Kim B.Y., Kim E.K. Clinical findings and treatments of granular corneal dystrophy type 2 (avellino corneal dystrophy): a review of the literature. Eye Contact Lens 2010, 36:296-299.
78. Han Y.P., Sim A.J., Vora S.C., Huang A.J. Unique TGFBI protein in lattice corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 2011, 52:8401-8406.
79. Han Y.P., Sim A.J., Vora S.C., Huang A.J. A unique TGFBI protein in granular corneal dystrophy types 1 and 2. Curr. eye Res. 2012, 37:990-996.
80. Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., Tokunaga C., Avruch J., Yonezawa K. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002, 110:177-189.
81. Hida T., Proia A.D., Kigasawa K., Sanfilippo F.P., Burchette J.L., Akiya S., Klintworth G.K. Histopathologic and immunochemical features of lattice corneal dystrophy type III. Am. J. Ophthalmol. 1987, 104:249-254.
82. Hida T., Tsubota K., Kigasawa K., Murata H., Ogata T., Akiya S. Clinical features of a newly recognized type of lattice corneal dystrophy. Am. J. Ophthalmol. 1987, 104:241-248.
83. Hieda O., Kawasaki S., Wakimasu K., Yamasaki K., Inatomi T., Kinoshita S. Clinical outcomes of phototherapeutic keratectomy in eyes with Thiel-Behnke corneal dystrophy. Am. J. Ophthalmol. 2013, 155. (66-72.e61).
84. Hirano K., Hotta Y., Nakamura M., Fujiki K., Kanai A., Yamamoto N. Late-onset form of lattice corneal dystrophy caused by leu527Arg mutation of the TGFBI gene. Cornea 2001, 20:525-529.
85. Hirano K., Klintworth G.K., Zhan Q., Bennett K., Cintron C. Beta ig-h3 is synthesized by corneal epithelium and perhaps endotheliumin Fuchs' dystrophic corneas. Curr. Eye Res. 1996, 15:965-972.
86. Holland E.J., Daya S.M., Stone E.M., Folberg R., Dobler A.A., Cameron J.D., Doughman D.J. Avellino corneal dystrophy. Clinical manifestations and natural history. Ophthalmology 1992, 99:1564-1568.
87. Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov S.A., Mankani M., Robey P.G., Poole A.R., Pidoux I., Ward J.M., Birkedal-Hansen H. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999, 99:81-92.
88. Jeon E.S., Kim J.H., Ryu H., Kim E.K. Lysophosphatidic acid activates TGFBIp expression in human corneal fibroblasts through a TGF-beta1-dependent pathway. Cell. Signal. 2012, 24:1241-1250.
89. Jester J.V., Moller-Pedersen T., Huang J., Sax C.M., Kays W.T., Cavangh H.D., Petroll W.M., Piatigorsky J. The cellular basis of corneal transparency: evidence for 'corneal crystallins'. J. Cell Sci. 1999, 112(Pt 5):613-622.
90. Johnson B.L., Brown S.I., Zaidman G.W. A light and electron microscopic study of recurrent granular dystrophy of the cornea. Am. J. Ophthalmol. 1981, 92:49-58.
91. Jun R.M., Tchah H., Kim T.I., Stulting R.D., Jung S.E., Seo K.Y., Lee D.H., Kim E.K. Avellino corneal dystrophy after LASIK. Ophthalmology 2004, 111:463-468.
92. Jung J.W., Kim S.A., Kang E.M., Kim T.I., Cho H.S., Kim E.K. Lattice corneal dystrophy type IIIA with hyaline component from a novel A620P mutation and distinct surgical treatments. Cornea 2014, 33:1324-1331.
93. Jung S.H., Han K.E., Stulting R.D., Sgrignoli B., Kim T.I., Kim E.K. Phototherapeutic keratectomy in diffuse stromal haze in granular corneal dystrophy type 2. Cornea 2013, 32:296-300.
94. Kaji Y., Soya K., Amano S., Oshika T., Yamashita H. Relation between corneal haze and transforming growth factor-beta1 after photorefractive keratectomy and laser in situ keratomileusis. J. Cataract Refract. Surg. 2001, 27:1840-1846.
95. Kamoi M., Mashima Y., Kawashima M., Tsubota K. Electrolysis for corneal opacities in a young patient with superficial variant of granular corneal dystrophy (Reis-Bucklers corneal dystrophy). Am. J. Ophthalmol. 2005, 139:1139-1140.
96. Karring H., Runager K., Valnickova Z., Thogersen I.B., Moller-Pedersen T., Klintworth G.K., Enghild J.J. Differential expression and processing of transforming growth factor beta induced protein (TGFBIp) in the normal human cornea during postnatal development and aging. Exp. Eye Res. 2010, 90:57-62.
97. Karring H., Runager K., Thogersen I.B., Klintworth G.K., Hojrup P., Enghild J.J. Composition and proteolytic processing of corneal deposits associated with mutations in the TGFBI gene. Exp. Eye Res. 2012, 96:163-170.
98. Karring H., Poulsen E.T., Runager K., Thogersen I.B., Klintworth G.K., Hojrup P., Enghild J.J. Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits. Mol. Vis. 2013, 19:861-876.
99. Kasai H., Hayami H., Yamaizumi Z., SaitoH, Nishimura S. Detection and identification of mutagens and carcinogens as their adducts with guanosine derivatives. Nucleic Acids Res. 1984, 12:2127-2136.
100. Kasai H., Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res. 1984, 12:2137-2145.
101. Kato M., Putta S., Wang M., Yuan H., Lanting L., Nair I., Gunn A., Nakagawa Y., Shimano H., Todorov I., Rossi J.J., Natarajan R. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol. 2009, 11:881-889.
102. Kato Y., Yagi H., Kaji Y., Oshika T., Goto Y. Benzalkonium chloride accelerates the formation of the amyloid fibrils of corneal dystrophy-associated peptides. J. Biol. Chem. 2013, 288:25109-25118.
103. Kawasaki S., Yagi H., Yamasaki K., Matsuda A., Takeda K., Kinoshita S. A novel mutation of the TGFBI gene causing a lattice corneal dystrophy with deep stromal involvement. Br. J. Ophthalmol. 2011, 95:150-151.
104. Kawashima M., Kawakita T., Den S., Shimmura S., Tsubota K., Shimazaki J. Comparison of deep lamellar keratoplasty and penetrating keratoplasty for lattice and macular corneal dystrophies. Am. J. Ophthalmol. 2006, 142:304-309.
105. Kim B.Y., Olzmann J.A., Choi S.I., Ahn S.Y., Kim T.I., Cho H.S., Suh H., Kim E.K. Corneal dystrophy-associated R124H mutation disrupts TGFBI interaction with periostin and causes mislocalization to the lysosome. J. Biol. Chem. 2009, 284:19580-19591.
106. Kim H.J., Kim I.S. Transforming growth factor-beta-induced gene product, as a novel ligand of integrin alphaMbeta2, promotes monocytes adhesion, migration and chemotaxis. Int. J. Biochem. Cell Biol. 2008, 40:991-1004.
107. Kim J., Lee K.A., Kim E.K., Lee H.K. A Korean patient with lattice corneal dystrophy type IV with Leu527Arg mutation in the TGFBI gene. Korean J. Ophthalmol. 2014, 28:83-85.
108. Kim J.E., Han M.S., Bae Y.C., Kim H.K., Kim T.I., Kim E.K., Kim I.S. Anterior segment dysgenesis after overexpression of transforming growth factor-beta-induced gene, beta igh3, in the mouse eye. Mol. Vis. 2007, 13:1942-1952.
109. Kim J.E., Jeong H.W., Nam J.O., Lee B.H., Choi J.Y., Park R.W., Park J.Y., Kim I.S. Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin. J. Biol. Chem. 2002, 277:46159-46165.
110. Kim M.O., Yun S.J., Kim I.S., Sohn S., Lee E.H. Transforming growth factor-beta-inducible gene-h3 (beta(ig)-h3) promotes cell adhesion of human astrocytoma cells in vitro: implication of alpha6beta4 integrin. Neurosci. Lett. 2003, 336:93-96.
111. Kim S.W., Lee H.Y., Kim T.I., Shin K.J., Yang W.I., Kim E.K. The survival of donor-derived cells in a successfully grafted corneal button 10 years after penetrating keratoplasty for lattice dystrophy. Ophthalmol. J. Int. d'ophtalmol. Int. J. Ophthalmol. Z. fur Augenheilkd. 2009, 223:396-400.
112. Kim T.I., Choi S.I., Lee H.K., Cho Y.J., Kim E.K. Mitomycin C induces apoptosis in cultured corneal fibroblasts derived from type II granular corneal dystrophy corneas. Mol. Vis. 2008, 14:1222-1228.
113. Kim T.I., Hong J.P., Ha B.J., Stulting R.D., Kim E.K. Determination of treatment strategies for granular corneal dystrophy type 2 using Fourier-domain optical coherence tomography. Br. J. Ophthalmol. 2010, 94:341-345.
114. Kim T.I., Kim H., Lee D.J., Choi S.I., Kang S.W., Kim E.K. Altered mitochondrial function in type 2 granular corneal dystrophy. Am. J. Pathol. 2011, 179:684-692.
115. Kim T.I., Kim T., Kim S.W., Kim E.K. Comparison of corneal deposits after LASIK and PRK in eyes with granular corneal dystrophy type II. J. Refract Surg. 2008, 24:392-395.
116. Kim T.I., Pak J.H., Chae J.B., Kim E.K., Tchah H. Mitomycin C inhibits recurrent Avellino dystrophy after phototherapeutic keratectomy. Cornea 2006, 25:220-223.
117. Kim T.I., Pak J.H., Lee S.Y., Tchah H. Mitomycin C-induced reduction of keratocytes and fibroblasts after photorefractive keratectomy. Invest. Ophthalmol. Vis. Sci. 2004, 45:2978-2984.
118. Kim T.I., Roh M.I., Grossniklaus H.E., Kang S.J., Hamilton S.M., Schorderet D.F., Lee W.B., Kim E.K. Deposits of transforming growth factor-beta-induced protein in granular corneal dystrophy type II after LASIK. Cornea 2008, 27:28-32.
119. Kitahama S., Gibson M.A., Hatzinikolas G., Hay S., Kuliwaba J.L., Evdokiou A., Atkins G.J., Findlay D.M. Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cells. Bone 2000, 27:61-67.
120. Klintworth G.K. Advances in the molecular genetics of corneal dystrophies. Am. J. Ophthalmol. 1999, 128:747-754.
121. Klintworth G.K., Bao W., Afshari N.A. Two mutations in the TGFBI (BIGH3) gene associated with lattice corneal dystrophy in an extensively studied family. Invest. Ophthalmol. Vis. Sci. 2004, 45:1382-1388.
122. Klintworth G.K., Valnickova Z., Enghild J.J. Accumulation of beta ig-h3 gene product in corneas with granular dystrophy. Am. J. Pathol. 1998, 152:743-748.
123. Kobayashi A., Ijiri S., Ohta T., Sugiyama K. Disappearance of honeycomb opacity of Thiel-Behnke corneal dystrophy after Thygeson superficial punctate keratitis. Cornea 2005, 24:1029-1030.
124. Kolter T., Wendeler M. Chemical chaperones - a new concept in drug research. Chembiochem 2003, 4:260-264.
125. Korvatska E., Henry H., Mashima Y., Yamada M., Bachmann C., Munier F.L., Schorderet D.F. Amyloid and non-amyloid forms of 5q31-linked corneal dystrophy resulting from kerato-epithelin mutations at Arg-124 are associated with abnormal turnover of the protein. J. Biol. Chem. 2000, 275:11465-11469.
126. Korvatska E., Munier F.L., Chaubert P., Wang M.X., Mashima Y., Yamada M., Uffer S., Zografos L., Schorderet D.F. On the role of kerato-epithelin in the pathogenesis of 5q31-linked corneal dystrophies. Invest. Ophthalmol. Vis. Sci. 1999, 40:2213-2219.
127. Kuchle M., Green W.R., Volcker H.E., Barraquer J. Reevaluation of corneal dystrophies of Bowman's layer and the anterior stroma (Reis-Bucklers and Thiel-Behnke types): a light and electron microscopic study of eight corneas and a review of the literature. Cornea 1995, 14:333-354.
128. Lakshminarayanan R., Vithana E.N., Chai S.M., Chaurasia S.S., Saraswathi P., Venkatraman A., Rojare C., Venkataraman D., Tan D., Aung T., Beuerman R.W., Mehta J.S. A novel mutation in transforming growth factor-beta induced protein (TGFbetaIp) reveals secondary structure perturbation in lattice corneal dystrophy. Br. J. Ophthalmol. 2011, 95:1457-1462.
129. Leung E.W., Rifle L., Smith R.E., Kay E.P. Extracellular matrix components in retrocorneal fibrous membrane in comparison to corneal endothelium and Descemet's membrane. Mol. Vis. 2000, 7:15-23.
130. Lee E.J., Kim K.J., Kim H.N., Bok J., Jung S.C., Kim E.K., Lee J.Y., Kim H.L. Genome-wide scan of granular corneal dystrophy, type II: confirmation of chromosome 5q31 and identification of new co-segregated loci on chromosome 3q26.3. Exp. Mol. Med. 2011, 43:393-400.
131. Lee J.H., Chung S.H., Stulting R.D., Kim W.C., Lee H.K., Kim E.K. Effects of corneal neovascularization on the manifestations of Avellino corneal dystrophy (granular corneal dystrophy type II). Cornea 2006, 25:914-918.
132. Lee J.H., Cristol S.M., Kim W.C., Chung E.S., Tchah H., Kim M.S., Nam C.M., Cho H.S., Kim E.K. Prevalence of granular corneal dystrophy type 2 (Avellino corneal dystrophy) in the Korean population. Ophthalmic Epidemiol. 2010, 17:160-165.
133. Lee J.J., Park K., Shin M.H., Yang W.J., Song M.J., Park J.H., Yong T.S., Kim E.K., Kim H.P. Accessible chromatin structure permits factors Sp1 and Sp3 to regulate human TGFBI gene expression. Biochem. Biophys. Res. Commun. 2011, 409:222-228.
134. Lee S.H., Bae J.S., Park S.H., Lee B.H., Park R.W., Choi J.Y., Park J.Y., Ha S.W., Kim Y.L., Kwon T.H., Kim I.S. Expression of TGF-beta-induced matrix protein betaig-h3 is up-regulated in the diabetic rat kidney and human proximal tubular epithelial cells treated with high glucose. Kidney Int. 2003, 64:1012-1021.
135. Lee W.B., Himmel K.S., Hamilton S.M., Zhao X.C., Yee R.W., Kang S.J., Grossniklaus H.E. Excimer laser exacerbation of Avellino corneal dystrophy. J. Cataract Refract. Surg. 2007, 33:133-138.
136. Lisch W., Seitz B. Lattice corneal dystrophy type 1: an epithelial or stromal entity?. Cornea 2014, 33:1109-1112.
137. Liskova P., Klintworth G.K., Bowling B.L., Filipec M., Jirsova K., Tuft S.J., Bhattacharya S.S., Hardcastle A.J., Ebenezer N.D. Phenotype associated with the H626P mutation and other changes in the TGFBI gene in Czech families. Ophthalmic Res. 2008, 40:105-108.
138. Long C., McAnally J.R., Shelton J.M., Mireault A.A., Bassel-Duby R., Olson E.N. Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA. Sci. (New York, N. Y. 2014, 345:1184-1188.
139. Lyons C.J., McCartney A.C., Kirkness C.M., Ficker L.A., Steele A.D., Rice N.S. Granular corneal dystrophy. Visual results and pattern of recurrence after lamellar or penetrating keratoplasty. Ophthalmology 1994, 101:1812-1817.
140. Maclean H., Robinson L.P., Wechsler A.W., Goh A. Excimer phototherapeutic keratectomy for recurrent granular dystrophy. Aust. N. Z. J. Ophthalmol. 1996, 24:127-130.
141. Maeng Y.S., Lee G.H., Choi S.I., Kim K.S., Kim E.K. Histone methylation levels correlate with TGFBIp and extracellular matrix gene expression in normal and granular corneal dystrophy type 2 corneal fibroblasts. BMC Med. Genomics 2015, 8:1-15.
142. Maeng Y.S., Aguilar B., Choi S.I., Kim E.K. Inhibition of TGFBIp expression reduces lymphangiogenesis and tumor metastasis. Oncogene 2015, [Epub ahead of print].
143. Maeng Y.S., Choi Y.J., Kim E.K. TGFBIp regulates differentiation of EPC (CD133(+) C-kit(+) Lin(-) cells) to EC through activation of the Notch signaling pathway. Stem Cells (Dayton, Ohio) 2015, 33:2052-2062.
144. Marcon A.S., Cohen E.J., Rapuano C.J., Laibson P.R. Recurrence of corneal stromal dystrophies after penetrating keratoplasty. Cornea 2003, 22:19-21.
145. Mashima Y., Kawai M., Yamada M. Corneal electrolysis for recurrence of corneal stromal dystrophy after keratoplasty. Br. J. Ophthalmol. 2002, 86:273-275.
146. Mashima Y., Konishi M., Nakamura Y., Imamura Y., Yamada M., Ogata T., Kudoh J., Shimizu N. Severe form of juvenile corneal stromal dystrophy with homozygous R124H mutation in the keratoepithelin gene in five Japanese patients. Br. J. Ophthalmol. 1998, 82:1280-1284.
147. Mashima Y., Nakamura Y., Noda K., Konishi M., Yamada M., Kudoh J., Shimizu N. A novel mutation at codon 124 (R124L) in the BIGH3 gene is associated with a superficial variant of granular corneal dystrophy. Arch. Ophthalmol. 1999, 117:90-93.
148. Mashima Y., Yamamoto S., Inoue Y., Yamada M., Konishi M., Watanabe H., Maeda N., Shimomura Y., Kinoshita S. Association of autosomal dominantly inherited corneal dystrophies with BIGH3 gene mutations in Japan. Am. J. Ophthalmol. 2000, 130:516-517.
149. Massague J. TGFbeta in Cancer. Cell 2008, 134:215-230.
150. Mates J.M., Perez-Gomez C., Nunez de Castro I. Antioxidant enzymes and human diseases. Clin. Biochem. 1999, 32:595-603.
151. Menasche M., Savoldelli M., Pouliquen Y. The keratocyte or fibroblast of the cornea: morphological and biochemical characteristics in normal stroma and a few cases of corneal dystrophies. Pathol. Biol. 1992, 40:871-878.
152. Miller A., Solomon R., Bloom A., Palmer C., Perry H.D., Donnenfeld E.D. Prevention of recurrent Reis-Bucklers dystrophy following excimer laser phototherapeutic keratectomy with topical mitomycin C. Cornea 2004, 23:732-735.
153. Moon J.W., Kim S.W., Kim T.I., Cristol S.M., Chung E.S., Kim E.K. Homozygous granular corneal dystrophy type II (Avellino corneal dystrophy): natural history and progression after treatment. Cornea 2007, 26:1095-1100.
154. Morita Y., Chikama T., Yamada N., Morishige N., Sonoda K.H., Nishida T. New mode of treatment for lattice corneal dystrophy type I: corneal epithelial debridement and fibronectin eye drops. Jpn. J. Ophthalmol. 2012, 56:26-30.
155. Munier F.L., Frueh B.E., Othenin-Girard P., Uffer S., Cousin P., Wang M.X., Heon E., Black G.C., Blasi M.A., Balestrazzi E., Lorenz B., Escoto R., Barraquer R., Hoeltzenbein M., Gloor B., Fossarello M., Singh A.D., Arsenijevic Y., Zografos L., Schorderet D.F. BIGH3 mutation spectrum in corneal dystrophies. Invest. Ophthalmol. Vis. Sci. 2002, 43:949-954.
156. Munier F.L., Korvatska E., Djemai A., Le Paslier D., Zografos L., Pescia G., Schorderet D.F. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat. Genet. 1997, 15:247-251.
157. Munishkina L.A., Fink A.L., Uversky V.N. Conformational prerequisites for formation of amyloid fibrils from histones. J. Mol. Biol. 2004, 342:1305-1324.
158. Nam E.J., Sa K.H., You D.W., Cho J.H., Seo J.S., Han S.W., Park J.Y., Kim S.I., Kyung H.S., Kim I.S., Kang Y.M. Up-regulated transforming growth factor beta-inducible gene h3 in rheumatoid arthritis mediates adhesion and migration of synoviocytes through alpha v beta3 integrin: regulation by cytokines. Arth. Rheumat. 2006, 54:2734-2744.
159. Nam J.O., Jeong H.W., Lee B.H., Park R.W., Kim I.S. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin. Cancer Res. 2005, 65:4153-4161.
160. Niel-Butschi F., Kantelip B., Iwaszkiewicz J., Zoete V., Boimard M., Delpech M., Bourges J.L., Renard G., D'Hermies F., Pisella P.J., Hamel C., Delbosc B., Valleix S. Genotype-phenotype correlations of TGFBI p.Leu509Pro, p.Leu509Arg, p.Val613Gly, and the allelic association of p.Met502Val-p.Arg555Gln mutations. Mol. Vis. 2011, 17:1192-1202.
161. Ohno S., Noshiro M., Makihira S., Kawamoto T., Shen M., Yan W., Kawashima-Ohya Y., Fujimoto K., Tanne K., Kato Y. RGD-CAP ((beta)ig-h3) enhances the spreading of chondrocytes and fibroblasts via integrin alpha(1)beta(1). Biochim. Biophys. Acta 1999, 1451:196-205.
162. Okada M., Yamamoto S., Inoue Y., Watanabe H., Maeda N., Shimomura Y., Ishii Y., Tano Y. Severe corneal dystrophy phenotype caused by homozygous R124H keratoepithelin mutations. Invest. Ophthalmol. Vis. Sci. 1998, 39:1947-1953.
163. Okada M., Yamamoto S., Watanabe H., Inoue Y., Tsujikawa M., Maeda N., Shimomura Y., Nishida K., Kinoshita S., Tano Y. Granular corneal dystrophy with homozygous mutations in the kerato-epithelin gene. Am. J. Ophthalmol. 1998, 126:169-176.
164. Oldak M., Szaflik J.P., Sciezynska A., Udziela M., Maksym R.B., Rymgayllo-Jankowska B., Hofmann-Rummelt C., Menzel-Severing J., Ploski R., Zarnowski T., Kruse F.E., Szaflik J. Late-onset lattice corneal dystrophy without typical lattice lines caused by a novel mutation in the TGFBI gene. Cornea 2014, 33:294-299.
165. Otori T. Electrolyte content of the rabbit corneal stroma. Exp. Eye Res. 1967, 6:356-367.
166. Ozawa D., Kaji Y., Yagi H., Sakurai K., Kawakami T., Naiki H., Goto Y. Destruction of amyloid fibrils of keratoepithelin peptides by laser irradiation coupled with amyloid-specific thioflavin T. J. Biol. Chem. 2011, 286:10856-10863.
167. Paliwal P., Sharma A., Tandon R., Sharma N., Titiyal J.S., Sen S., Kaur P., Dube D., Vajpayee R.B. TGFBI mutation screening and genotype-phenotype correlation in north Indian patients with corneal dystrophies. Mol. Vis. 2010, 16:1429-1438.
168. Pampukha V.N., Kravchenko S.A., Tereshchenko F., Drozhzhina G.I., Livshits L.A. TGFBI gene mutations in the Ukrainian patients with inherited corneal stromal dystrophies. Genetika 2008, 44:1392-1396.
169. Pandrowala H., Bansal A., Vemuganti G.K., Rao G.N. Frequency, distribution, and outcome of keratoplasty for corneal dystrophies at a tertiary eye care center in South India. Cornea 2004, 23:541-546.
170. Pang C.P., Lam D.S. Differential occurrence of mutations causative of eye diseases in the Chinese population. Hum. Mutat. 2002, 19:189-208.
171. Park K.A., Ki C.S., Chung E.S., Chung T.Y. Deep anterior lamellar keratoplasty in Korean patients with Avellino dystrophy. Cornea 2007, 26:1132-1135.
172. Park S.W., Bae J.S., Kim K.S., Park S.H., Lee B.H., Choi J.Y., Park J.Y., Ha S.W., Kim Y.L., Kwon T.H., Kim I.S., Park R.W. Beta ig-h3 promotes renal proximal tubular epithelial cell adhesion, migration and proliferation through the interaction with alpha3beta1 integrin. Exp. Mol. Med. 2004, 36:211-219.
173. Park S.Y., Jung M.Y., Kim I.S. Stabilin-2 mediates homophilic cell-cell interactions via its FAS1 domains. FEBS Lett. 2009, 583:1375-1380.
174. Poulsen E.T., Runager K., Risor M.W., Dyrlund T.F., Scavenius C., Karring H., Praetorius J., Vorum H., Otzen D.E., Klintworth G.K., Enghild J.J. Comparison of two phenotypically distinct lattice corneal dystrophies caused by mutations in the transforming growth factor beta induced (TGFBI) gene. Proteom. Clin. Appl. 2014, 8:168-177.
175. Rao N.A., Romero J.L., Fernandez M.A., Sevanian A., Marak G.E. Role of free radicals in uveitis. Surv. Ophthalmol. 1987, 32:209-213.
176. Rawe I.M., Zhan Q., Burrows R., Bennett K., Cintron C. Beta-ig. Molecular cloning and in situ hybridization in corneal tissues. Invest. Ophthalmol. Vis. Sci. 1997, 38:893-900.
177. Reinhard T., Sundmacher R., Spelsberg H., Althaus C. Homologous penetrating central limbo-keratoplasty (HPCLK) in bilateral limbal stem cell insufficiency. Acta Ophthalmol. Scand. 1999, 77:663-667.
178. Reis W. Familiare, fleckige Hornhautentartung. Dtsch. Med. Wochenschr. 1917, 43:575.
179. Richard J.M., Paton D., Gasset A.R. A comparison of penetrating keratoplasty and lamellar keratoplasty in the surgical management of keratoconus. Am. J. Ophthalmol. 1978, 86:807-811.
180. Ridgway A.E., Akhtar S., Munier F.L., Schorderet D.F., Stewart H., Perveen R., Bonshek R.E., Odenthal M.T., Dixon M., Barraquer R., Escoto R., Black G.C. Ultrastructural and molecular analysis of Bowman's layer corneal dystrophies: an epithelial origin?. Invest. Ophthalmol. Vis. Sci. 2000, 41:3286-3292.
181. Rodrigues M.M., Streeten B.W., Krachmer J.H., Laibson P.R., Salem N., Passonneau J., Chock S. Microfibrillar protein and phospholipid in granular corneal dystrophy. Arch. Ophthalmol. 1983, 101:802-810.
182. Roh M.I., Chung S.H., Stulting R.D., Kim W.C., Kim E.K. Preserved peripheral corneal clarity after surgical trauma in patients with Avellino corneal dystrophy. Cornea 2006, 25:497-498.
183. Roh M.I., Grossniklaus H.E., Chung S.H., Kang S.J., Kim W.C., Kim E.K. Avellino corneal dystrophy exacerbated after LASIK: scanning electron microscopic findings. Cornea 2006, 25:306-311.
184. Romero P., Moraga M., Herrera L. Different phenotypes of lattice corneal dystrophy type I in patients with 417C>T (R124C) and 1762A>G (H572R) mutations in TGFBI (BIGH3). Mol. Vis. 2010, 16:1601-1609.
185. Rosenwasser G.O., Sucheski B.M., Rosa N., Pastena B., Sebastiani A., Sassani J.W., Perry H.D. Phenotypic variation in combined granular-lattice (Avellino) corneal dystrophy. Arch. Ophthalmol. 1993, 111:1546-1552.
186. Rozzo C., Fossarello M., Galleri G., Sole G., Serru A., Orzalesi N., Serra A., Pirastu M. A common beta ig-h3 gene mutation (delta f540) in a large cohort of Sardinian Reis Bucklers corneal dystrophy patients. Mutations in brief no. 180. Hum. Mutat. 1998, 12:215-216. Online.
187. Runager K., Klintworth G.K., Karring H., Enghild J.J. The insoluble TGFBIp fraction of the cornea is covalently linked via a disulfide bond to type XII collagen. Biochemistry 2013, 52:2821-2827.
188. Runager K., Basaiawmoit R.V., Deva T., Andreasen M., Valnickova Z., Sorensen C.S., Karring H., Thogersen I.B., Christiansen G., Underhaug J., Kristensen T., Nielsen N.C., Klintworth G.K., Otzen D.E., Enghild J.J. Human phenotypically distinct TGFBI corneal dystrophies are linked to the stability of the fourth FAS1 domain of TGFBIp. J. Biol. Chem. 2011, 286:4951-4958.
189. Saika S., Saika S., Liu C.Y., Azhar M., Sanford L.P., Doetschman T., Gendron R.L., Kao C.W., Kao W.W. TGFbeta2 in corneal morphogenesis during mouse embryonic development. Dev. Biol. 2001, 240:419-432.
190. Sakimoto T., Kanno H., Shoji J., Kashima Y., Nakagawa S., Miwa S., Sawa M. A novel nonsense mutation with a compound heterozygous mutation in TGFBI gene in lattice corneal dystrophy type I. Jpn. J. Ophthalmol. 2003, 47:13-17.
191. Salouti R., Hosseini H., Eghtedari M., Khalili M.R. Deep anterior lamellar keratoplasty with melles technique for granular corneal dystrophy. Cornea 2009, 28:140-143.
192. Schmitt-Bernard C.F., Chavanieu A., Derancourt J., Arnaud B., Demaille J.G., Calas B., Argiles A. In vitro creation of amyloid fibrils from native and Arg124Cys mutated betaIGH3((110-131)) peptides, and its relevance for lattice corneal amyloid dystrophy type I. Biochem. Biophys. Res. Commun. 2000, 273:649-653.
193. Schmitt-Bernard C.F., Chavanieu A., Herrada G., Subra G., Arnaud B., Demaille J.G., Calas B., Argiles A. BIGH3 (TGFBI) Arg124 mutations influence the amyloid conversion of related peptides in vitro. Eur. J. Biochem./FEBS 2002, 269:5149-5156.
194. Schmitt-Bernard C.F., Guittard C., Arnaud B., Demaille J., Argiles A., Claustres M., Tuffery-Giraud S. BIGH3 exon 14 mutations lead to intermediate type I/IIIA of lattice corneal dystrophies. Invest. Ophthalmol. Vis. Sci. 2000, 41:1302-1308.
195. Schroder M., Kaufman R.J. ER stress and the unfolded protein response. Mutat. Res. 2005, 569:29-63.
196. Seitz B., Behrens A., Fischer M., Langenbucher A., Naumann G.O. Morphometric analysis of deposits in granular and lattice corneal dystrophy: histopathologic implications for phototherapeutic keratectomy. Cornea 2004, 23:380-385.
197. Seitz B., Lisch W. Stage-related therapy of corneal dystrophies. Dev. Ophthalmol. 2011, 48:116-153.
198. Seitz B., Weidle E., Naumann G.O. Unilateral type III (Hida) lattice stromal corneal dystrophy. Klin. Monatsblatter fur Augenheilkd. 1993, 203:279-285.
199. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995, 9:1149-1163.
200. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
201. Skonier J., Neubauer M., Madisen L., Bennett K., Plowman G.D., Purchio A.F. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol. 1992, 11:511-522.
202. Sokolov Y., Kozak J.A., Kayed R., Chanturiya A., Glabe C., Hall J.E. Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure. J. Gen. Physiol. 2006, 128:637-647.
203. Sorensen C.S., Runager K., Scavenius C., Jensen M.M., Nielsen N.S., Christiansen G., Petersen S.V., Karring H., Sanggaard K.W., Enghild J.J. Fibril core of transforming growth factor beta-induced protein (TGFBIp) facilitates aggregation of corneal TGFBIp. Biochemistry 2015, 54:2943-2956.
204. Sornson E.T. Granular dystrophy of the cornea: an electron microscopic study. Am. J. Ophthalmol. 1965, 59:1001-1007.
205. Sorour H.M., Yee S.B., Peterson N.J., Li F.T., Macsai M.S., Zhao X.C., Yee R.W. Recurrence of chromosome 10 Thiel-Behnke corneal dystrophy (CDB2) after excimer laser phototherapeutic keratectomy or penetrating keratoplasty. Cornea 2005, 24:45-50.
206. Spelsberg H., Reinhard T., Henke L., Berschick P., Sundmacher R. Penetrating limbo-keratoplasty for granular and lattice corneal dystrophy: survival of donor limbal stem cells and intermediate-term clinical results. Ophthalmology 2004, 111:1528-1533.
207. Sridhar M.S., Laibson P.R., Eagle R.C., Rapuano C.J., Cohen E.J. Unilateral corneal lattice dystrophy. Cornea 2001, 20:850-852.
208. Sridhar M.S., Pandrowala H., Rao G.N. Unilateral lattice dystrophy in an elderly patient. Eye Lond. Engl. 2002, 16:653-655.
209. Stewart H., Black G.C., Donnai D., Bonshek R.E., McCarthy J., Morgan S., Dixon M.J., Ridgway A.A. A mutation within exon 14 of the TGFBI (BIGH3) gene on chromosome 5q31 causes an asymmetric, late-onset form of lattice corneal dystrophy. Ophthalmology 1999, 106:964-970.
210. Stewart H.S., Ridgway A.E., Dixon M.J., Bonshek R., Parveen R., Black G. Heterogeneity in granular corneal dystrophy: identification of three causative mutations in the TGFBI (BIGH3) gene-lessons for corneal amyloidogenesis. Hum. Mutat. 1999, 14:126-132.
211. Stix B., Leber M., Bingemer P., Gross C., Ruschoff J., Fandrich M., Schorderet D.F., Vorwerk C.K., Zacharias M., Roessner A., Rocken C. Hereditary lattice corneal dystrophy is associated with corneal amyloid deposits enclosing C-terminal fragments of keratoepithelin. Invest. Ophthalmol. Vis. Sci. 2005, 46:1133-1139.
212. Sundmacher R., Spelsberg H., Reinhard T. Homologous penetrating central limbokeratoplasty in granular and lattice corneal dystrophy. Cornea 1999, 18:664-670.
213. Takacs L., Csutak A., Balazs E., Berta A. Immunohistochemical detection of betaIG-H3 in scarring human corneas. Graefe's Arch. Clin. Exp. Ophthalmol.=Albrecht von Graefes Archiv fur klinische und Exp. Ophthalmol. 1999, 237:529-534.
214. Takacs L., Losonczy G., Matesz K., Balogh I., Sohajda Z., Toth K., Fazakas F., Vereb G., Berta A. TGFBI (BIGH3) gene mutations in Hungary - report of the novel F547S mutation associated with polymorphic corneal amyloidosis. Mol. Vis. 2007, 13:1976-1983.
215. Thiel H.J., Behnke H. A hitherto unknown subepithelial hereditary corneal dystrophy. Klin. Monatsblatter fur Augenheilkd. 1967, 150:862-874.
216. Tian X., Fujiki K., Wang W., Murakami A., Xie P., Kanai A., Liu Z. Novel mutation (V505D) of the TGFBI gene found in a Chinese family with lattice corneal dystrophy, type I. Jpn. J. Ophthalmol. 2005, 49:84-88.
217. Tian X., Fujiki K., Zhang Y., Murakami A., Li Q., Kanai A., Wang W., Hao Y., Ma Z. A novel variant lattice corneal dystrophy caused by association of mutation (V625D) in TGFBI gene. Am. J. Ophthalmol. 2007, 144:473-475.
218. Tsujikawa K., Tsujikawa M., Watanabe H., Maeda N., Inoue Y., Fujikado T., Tano Y. Allelic homogeneity in Avellino corneal dystrophy due to a founder effect. J. Hum. Genet. 2007, 52:92-97.
219. Ulloa-Aguirre A., Janovick J.A., Brothers S.P., Conn P.M. Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease. Traffic 2004, 5:821-837.
220. Unal M., Arslan O.S., Atalay E., Mangan M.S., Bilgin A.B. Deep anterior lamellar keratoplasty for the treatment of stromal corneal dystrophies. Cornea 2013, 32:301-305.
221. Underhaug J., Koldso H., Runager K., Nielsen J.T., Sorensen C.S., Kristensen T., Otzen D.E., Karring H., Malmendal A., Schiott B., Enghild J.J., Nielsen N.C. Mutation in transforming growth factor beta induced protein associated with granular corneal dystrophy type 1 reduces the proteolytic susceptibility through local structural stabilization. Biochim. Biophys. Acta 2013, 1834:2812-2822.
222. Vajpayee R.B., Tyagi J., Sharma N., Kumar N., Jhanji V., Titiyal J.S. Deep anterior lamellar keratoplasty by big-bubble technique for treatment corneal stromal opacities. Am. J. Ophthalmol. 2007, 143:954-957.
223. Van Amersfoort E.S., Van Strijp J.A. Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes. Cytometry 1994, 17:294-301.
224. Volles M.J., Lansbury P.T. Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 2002, 41:4595-4602.
225. Wan X.H., Lee H.C., Stulting R.D., Kim T., Jung S.E., Kim M.J., Kim E.K. Exacerbation of Avellino corneal dystrophy after laser in situ keratomileusis. Cornea 2002, 21:223-226.
226. Wang D.A., Du H., Jaggar J.H., Brindley D.N., Tigyi G.J., Watsky M.A. Injury-elicited differential transcriptional regulation of phospholipid growth factor receptors in the cornea. Am. J. Physiol. Cell physiol. 2002, 283:C1646-C1654.
227. Warren J.F., Abbott R.L., Yoon M.K., Crawford J.B., Spencer W.H., Margolis T.P. A new mutation (Leu569Arg) within exon 13 of the TGFBI (BIGH3) gene causes lattice corneal dystrophy type I. Am. J. Ophthalmol. 2003, 136:872-878.
228. Watanabe H., Hashida Y., Tsujikawa K., Tsujikawa M., Maeda N., Inoue Y., Yamamoto S., Tano Y. Two patterns of opacity in corneal dystrophy caused by the homozygous BIG-H3 R124H mutation. Am. J. Ophthalmol. 2001, 132:211-216.
229. Weidle E., Lisch W. Various forms of opacities of granular corneal dystrophy. Klin. Monbl. Augenheilkd. 1984, 185:167-173.
230. Weiss J.S., Moller H.U., Aldave A.J., Seitz B., Bredrup C., Kivela T., Munier F.L., Rapuano C.J., Nischal K.K., Kim E.K., Sutphin J., Busin M., Labbe A., Kenyon K.R., Kinoshita S., Lisch W. IC3D classification of corneal dystrophies - edition 2. Cornea 2015, 34:117-159.
231. Weiss J.S., Moller H.U., Lisch W., Kinoshita S., Aldave A.J., Belin M.W., Kivela T., Busin M., Munier F.L., Seitz B., Sutphin J., Bredrup C., Mannis M.J., Rapuano C.J., Van Rij G., Kim E.K., Klintworth G.K. The IC3D classification of the corneal dystrophies. Cornea 2008, 27(Suppl. 2):S1-S83.
232. Wenk J., Brenneisen P., Meewes C., Wlaschek M., Peters T., Blaudschun R., Ma W., Kuhr L., Schneider L., Scharffetter-Kochanek K. UV-induced oxidative stress and photoaging. Curr. Prob. Dermatol. 2001, 29:83-94.
233. Werner L.P., Werner L., Dighiero P., Legeais J.M., Renard G. Confocal microscopy in Bowman and stromal corneal dystrophies. Ophthalmology 1999, 106:1697-1704.
234. Wheeldon C.E., de Karolyi B.H., Patel D.V., Sherwin T., McGhee C.N., Vincent A.L. A novel phenotype-genotype relationship with a TGFBI exon 14 mutation in a pedigree with a unique corneal dystrophy of Bowman's layer. Mol. Vis. 2008, 14:1503-1512.
235. Wittebol-Post D., van der Want J.J., van Bijsterveld O.P. Granular dystrophy of the cornea (Groenouw's type I). Is the keratocyte the primary source after all?. Ophthalmol. J. Int. d'ophtalmol. Int. J. Ophthalmol. Z. fur Augenheilkd. 1987, 195:169-177.
236. Yam G.H., Wang K., Jhanji V., Choy K.W., Baum L., Pang C.P. In vitro amyloid aggregate forming ability of TGFBI mutants that cause corneal dystrophies. Invest. Ophthalmol. Vis. Sci. 2012, 53:5890-5898.
237. Yamada N., Kawamoto K., Morishige N., Chikama T., Nishida T., Nishioka M., Okayama N., Hinoda Y. Double mutation (R124H, N544S) of TGFBI in two sisters with combined expression of Avellino and lattice corneal dystrophies. Mol. Vis. 2009, 15:974-979.
238. Yamamoto S., Okada M., Tsujikawa M., Shimomura Y., Nishida K., Inoue Y., Watanabe H., Maeda N., Kurahashi H., Kinoshita S., Nakamura Y., Tano Y. A kerato-epithelin (betaig-h3) mutation in lattice corneal dystrophy type IIIA. Am. J. Hum. Genet. 1998, 62:719-722.
239. Yamazoe K., Yoshida S., Yasuda M., Hatou S., Inagaki E., Ogawa Y., Tsubota K., Shimmura S. Development of a transgenic mouse with R124H human TGFBI mutation associated with granular corneal dystrophy type 2. PLoS One 2015, 10:e0133397.
240. Yang J., Han X., Huang D., Yu L., Zhu Y., Tong Y., Zhu B., Li C., Weng M., Ma X. Analysis of TGFBI gene mutations in Chinese patients with corneal dystrophies and review of the literature. Mol. Vis. 2010, 16:1186-1193.
241. Yang Q.N., Zhao Y.W., Guo L.H., Yan N.H., Liu X.Y., Cai S.P. Arg124Cys mutation of the TGFBI gene in a Chinese pedigree of Reis-Bucklers corneal dystrophy. Int. J. Ophthalmol. 2011, 4:235-238.
242. Yellore V.S., Rayner S.A., Aldave A.J. TGFB1-induced extracellular expression of TGFBIp and inhibition of TGFBIp expression by RNA interference in a human corneal epithelial cell line. Invest. Ophthalmol. Vis. Sci. 2011, 52:757-763.
243. Yellore V.S., Sonmez B., Rayner S.A., Aldave A.J. A late-onset unilateral variant of lattice corneal dystrophy not associated with a TGFBI mutation. Br. J. Ophthalmol. 2008, 92:426-427.
244. Yu P., Gu Y., Yang Y., Yan X., Chen L., Ge Z., Qi M., Si J., Guo L. A clinical and molecular-genetic analysis of Chinese patients with lattice corneal dystrophy and novel Thr538Pro mutation in the TGFBI (BIGH3) gene. J. Genet. 2006, 85:73-76.
245. Yuan C., Berscheit H.L., Huang A.J. Identification of an amyloidogenic region on keratoepithelin via synthetic peptides. FEBS Lett. 2007, 581:241-247.
246. Yuan C., Zins E.J., Clark A.F., Huang A.J. Suppression of keratoepithelin and myocilin by small interfering RNAs (siRNA) in vitro. Mol. Vis. 2007, 13:2083-2095.
247. Zenteno J.C., Correa-Gomez V., Santacruz-Valdez C., Suarez-Sanchez R., Villanueva-Mendoza C. Clinical and genetic features of TGFBI-linked corneal dystrophies in Mexican population: description of novel mutations and novel genotype-phenotype correlations. Exp. Eye Res. 2009, 89:172-177.
248. Zenteno J.C., Ramirez-Miranda A., Santacruz-Valdes C., Suarez-Sanchez R. Expanding the mutational spectrum in TGFBI-linked corneal dystrophies: Identification of a novel and unusual mutation (Val113Ile) in a family with granular dystrophy. Mol. Vis. 2006, 12:331-335.
249. Zerovnik E. Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. Eur. J. Biochem./FEBS 2002, 269:3362-3371.
250. Zhang C., Zeng G., Lin H., Li D., Zhao L., Zhou N., Qi Y. A novel mutation I522N within the TGFBI gene caused lattice corneal dystrophy I. Mol. Vis. 2009, 15:2498-2502.
251. Zhong X., Chen S., Huang W., Yang J., Chen X., Zhou Y., Zhou Q., Wang Y. Novel and known mutations of TGFBI, their genotype-phenotype correlation and structural modeling in 3 Chinese families with lattice corneal dystrophy. Mol. Vis. 2010, 16:224-230.
252. Zhu M., Yu P., Jiang B., Gu Y. Investigation of the influence of Arg555Trp and Thr538Pro TGFBI mutations on C-terminal cleavage and cell endoplasmic reticulum stress. Mol. Vis. 2012, 18:1156-1164.